Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery.

Nondegradable synthetic polymer vascular grafts currently used in cardiovascular surgery have no growth potential. Tissue-engineered vascular grafts (TEVGs) may solve this problem. In this study, we developed a TEVG using autologous bone marrow-derived cells (BMCs) and decellularized tissue matrices, and tested whether the TEVGs exhibit growth potential and vascular remodeling in vivo. Vascular smooth muscle-like cells and endothelial-like cells were differentiated from bone marrow mononuclear cells in vitro. TEVGs were fabricated by seeding these cells onto decellularized porcine abdominal aortas and implanted into the abdominal aortas of 4-month-old, bone marrow donor pigs (n = 4). Eighteen weeks after implantation, the dimensions of TEVGs were measured and compared with those of native abdominal aortas. Expression of molecules associated with vascular remodeling was examined with reverse transcription-polymerase chain reaction assay and immunohistochemistry. Eighteen weeks after implantation, all TEVGs were patent with no sign of thrombus formation, dilatation, or stenosis. Histological and immunohistochemical analyses of the retrieved TEVGs revealed regeneration of endothelium and smooth muscle and the presence of collagen and elastin. The outer diameter of three of the four TEVGs increased in proportion to increases in body weight and outer native aorta diameter. Considerable extents of expression of molecules associated with extracellular matrix (ECM) degradation (i.e., matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase) and ECM precursors (i.e., procollagen I, procollagen III, and tropoelastin) occurred in the TEVGs, indicating vascular remodeling associated with degradation of exogenous ECMs (implanted decellularized matrices) and synthesis of autologous ECMs. This study demonstrates that the TEVGs with autologous BMCs and decellularized tissue matrices exhibit growth potential and vascular remodeling in vivo of tissue-engineered artery.

[1]  V. Bernhard,et al.  Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. , 1986, Journal of vascular surgery.

[2]  R. Chard,et al.  Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients. , 1987, The Journal of thoracic and cardiovascular surgery.

[3]  V. Koteliansky,et al.  Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. , 1993, Blood.

[4]  L. Ala‐Kokko,et al.  Origin of extracellular matrix synthesis during coronary repair. , 1997, Circulation.

[5]  G. Schultz,et al.  Expression of proteinases and proteinase inhibitors during embryo-uterine contact in the pig. , 1997, Developmental genetics.

[6]  J. Michel,et al.  The immunogenicity of the extracellular matrix in arterial xenografts. , 1997, Surgery.

[7]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[8]  R Langer,et al.  Creation of viable pulmonary artery autografts through tissue engineering. , 1998, The Journal of thoracic and cardiovascular surgery.

[9]  J. Miller,et al.  Long‐term results of femorotibial bypass with vein or polytetrafluoroethylene , 1998, The British journal of surgery.

[10]  Y. Taira,et al.  Increased tropoelastin and procollagen expression in the lung of nitrofen-induced diaphragmatic hernia in rats. , 1999, Journal of pediatric surgery.

[11]  M A Moses,et al.  Tissue engineering of autologous aorta using a new biodegradable polymer. , 1999, The Annals of thoracic surgery.

[12]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[13]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[14]  P. Hagen,et al.  Remodeling of an acellular collagen graft into a physiologically responsive neovessel , 1999, Nature Biotechnology.

[15]  A. Freemont,et al.  Birth associated changes in pulmonary arterial connective tissue gene expression in the normal and hypertensive lung. , 2000, Cardiovascular research.

[16]  P. Libby,et al.  Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy , 2001, Nature Medicine.

[17]  N. Hibino,et al.  Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. , 2001, Tissue engineering.

[18]  J. Michel,et al.  Extracellular matrix remodeling in the vascular wall. , 2001, Pathologie-biologie.

[19]  A. Haverich,et al.  Cell seeded decellularised allogeneic matrix grafts and biodegradable polydioxanone-prostheses compared with arterial autografts in a porcine model. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[20]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[21]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[22]  Y. Ikada,et al.  First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In Vivo , 2003, Circulation.

[23]  Narutoshi Hibino,et al.  Successful application of tissue engineered vascular autografts: clinical experience. , 2003, Biomaterials.

[24]  J. Moake,et al.  This article has been cited by other articles , 2003 .

[25]  H. Daida,et al.  Isolation of Bone Marrow Stromal Cell–Derived Smooth Muscle Cells by a Human SM22&agr; Promoter: In Vitro Differentiation of Putative Smooth Muscle Progenitor Cells of Bone Marrow , 2003, Circulation.

[26]  G. Vilahur,et al.  Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells. , 2003, Atherosclerosis.

[27]  David A. Vorp,et al.  Gene Expression Is Altered in Perfused Arterial Segments Exposed to Cyclic Flexure Ex Vivo , 1999, Annals of Biomedical Engineering.

[28]  M. Yamagishi,et al.  Application of real-time RT-PCR to quantifying gene expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human abdominal aortic aneurysm. , 2004, Atherosclerosis.

[29]  Zong-ping Luo,et al.  The combined regulation of estrogen and cyclic tension on fibroblast biosynthesis derived from anterior cruciate ligament. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[30]  柏倉 祐司.  Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22α promoter : In vitro differentiation of putative smooth muscle progenitor cells of bone marrow , 2004 .

[31]  Lloyd Wolfinbarger,et al.  Recellularization of decellularized allograft scaffolds in ovine great vessel reconstructions. , 2005, The Annals of thoracic surgery.

[32]  Narutoshi Hibino,et al.  Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. , 2005, The Journal of thoracic and cardiovascular surgery.

[33]  Honglin Luo,et al.  Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9. , 2005, Journal of vascular surgery.

[34]  Seung‐Woo Cho,et al.  Small-Diameter Blood Vessels Engineered With Bone Marrow–Derived Cells , 2005, Annals of surgery.

[35]  I. Shapiro,et al.  In vivo behavior of decellularized vein allograft. , 2005, The Journal of surgical research.

[36]  R. Günther,et al.  Multislice computed tomography perfusion imaging for visualization of acute pulmonary embolism: animal experience , 2005, European Radiology.

[37]  D. Atsma,et al.  Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. , 2005, Cardiovascular research.

[38]  I. Shapiro,et al.  In Vivo Behavior of Decellularized Vein Allograft1,2 , 2005 .

[39]  Seung‐Woo Cho,et al.  Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold. , 2006, Journal of vascular surgery.

[40]  Seung‐Woo Cho,et al.  Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. , 2006, Journal of biomedical materials research. Part A.

[41]  Hidetsugu Hori,et al.  In vivo recellularization of plain decellularized xenografts with specific cell characterization in the systemic circulation: histological and immunohistochemical study. , 2006, Artificial organs.

[42]  Stefan Agewall,et al.  Matrix metalloproteinases and cardiovascular disease. , 2006, European heart journal.

[43]  Frederick J. Schoen,et al.  Functional Growth in Tissue-Engineered Living, Vascular Grafts: Follow-Up at 100 Weeks in a Large Animal Model , 2006, Circulation.

[44]  K. Witter,et al.  Tissue reaction to three different types of tissue glues in an experimental aorta dissection model: a quantitative approach , 2010, Histochemistry and Cell Biology.

[45]  J. Mayer,et al.  Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study. , 2010, Tissue engineering. Part C, Methods.